Angiotensin-converting enzyme inhibition and prostaglandins (Q41552916)

3 October 2017

Angiotensin-converting enzyme inhibition and prostaglandins (English)

1 reference

Cardiology and cardiovascular medicine

3 October 2017

1 reference

https://api.crossref.org/works/10.1016/0002-9149(82)90351-4

15 September 2023

author name string

S. L. Swartz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6280473

15 September 2023

G. H. Williams

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6280473

15 September 2023

language of work or name

English

0 references

publication date

1 April 1982

1 reference

3 October 2017

21 April 1982

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6280473

full work available at URL

15 September 2023

https://api.elsevier.com/content/article/PII:0002914982903514?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9149(82)90351-4

https://api.elsevier.com/content/article/PII:0002914982903514?httpAccept=text/plain

15 September 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9149(82)90351-4

American Journal of Cardiology

15 September 2023

published in

1 reference

3 October 2017

49

1 reference

3 October 2017

6

1 reference

3 October 2017

1405-1409

1 reference

Converting enzyme inhibition in essential hypertension: the hypotensive response does not reflect only reduced angiotensin II formation

3 October 2017

1

1 reference

https://api.crossref.org/works/10.1016/0002-9149(82)90351-4

The effects of captopril (SQ 14,225) on bradykinin-induced bronchoconstriction in the anesthetized guinea pig

15 September 2023

3

1 reference

https://api.crossref.org/works/10.1016/0002-9149(82)90351-4

Prostacyclin mediates the potentiated hypotensive effect of bradykinin following captopril treatment

15 September 2023

4

1 reference

https://api.crossref.org/works/10.1016/0002-9149(82)90351-4

The effect of converting enzyme inhibition with SQ20,881 on plasma and urinary kinins, prostaglandin E, and angiotensin II in hypertensive man

15 September 2023

5

1 reference

https://api.crossref.org/works/10.1016/0002-9149(82)90351-4

Captopril-induced changes in prostaglandin production: relationship to vascular responses in normal man

15 September 2023

6

1 reference

https://api.crossref.org/works/10.1016/0002-9149(82)90351-4

Contribution of prostaglandins to the antihypertensive action of captopril in essential hypertension

15 September 2023

7

1 reference

https://api.crossref.org/works/10.1016/0002-9149(82)90351-4

Endocrine profile in the long-term phase of converting-enzyme inhibition

15 September 2023

9

1 reference

https://api.crossref.org/works/10.1016/0002-9149(82)90351-4

Plasma concentration and the depressor response to bradykinin infusion

15 September 2023

10

1 reference

https://api.crossref.org/works/10.1016/0002-9149(82)90351-4

Reciprocal influence of salt intake on adrenal glomerulosa and renal vascular responses to angiotensin II in normal man.

15 September 2023

11

1 reference

https://api.crossref.org/works/10.1016/0002-9149(82)90351-4

15 September 2023

Identifiers

1 reference

3 October 2017

1 reference